MedPath

Stimulation Therapy for Apnea: Reporting Thoughts

Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: Upper airway stimulation (Inspire Medical Systems, Inc.)
Registration Number
NCT04768543
Lead Sponsor
University of Pittsburgh
Brief Summary

Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • 18 years of age and older
  • ADHERE registry patient
  • Received UAS implant from June 2017 to present
Exclusion Criteria
  • Patients without up to date contact information

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ExposureUpper airway stimulation (Inspire Medical Systems, Inc.)Patients with moderate to severe OSA treated with UAS (Inspire Medical Systems, Inc)
Primary Outcome Measures
NameTimeMethod
Experiences with UAS therapyup to 4 years

individual qualitative interview via telephone

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath